State AGs Move to Block Corteva's Planned Separation Over PFAS Claims
CTVA sits 36% above its 52-week low of $60.535.
Summary
A group of state attorneys general is seeking to halt Corteva's planned separation into two companies, alleging the spin-off would leave insufficient assets to cover PFAS liabilities. Corteva categorically rejects the allegations as unfounded, unprecedented, speculative and unproven, says it will vigorously defend the separation, and asserts its balance sheet can absorb any potential liability. This legal challenge introduces new uncertainty around the timing and structure of the Vylor spin-off, which has been progressing through financing and debt exchange steps since August. A court decision on the AGs' request or any injunction will determine whether the separation proceeds on schedule.
At the time of this announcement, CTVA was trading at $82.54 on NYSE in the Life Sciences sector, with a market capitalization of approximately $55.1B. The 52-week trading range was $60.54 to $90.97. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Wiseek News.